Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA.
Saved in:
| Title: | Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell-free RNA. |
|---|---|
| Authors: | Metzenmacher M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Germany., Zaun G; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Germany., Trajkovic-Arsic M; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, a partnership between German Cabcer Research Center (DKFZ) and University Hospital Essen, Germany.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Cheung P; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, a partnership between German Cabcer Research Center (DKFZ) and University Hospital Essen, Germany.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Reissig TM; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Germany.; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, a partnership between German Cabcer Research Center (DKFZ) and University Hospital Essen, Germany.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Schürmann H; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Germany.; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, a partnership between German Cabcer Research Center (DKFZ) and University Hospital Essen, Germany.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., von Neuhoff N; Department of Pediatric Hematology and Oncology, Department for Pediatrics III, University Hospital of Essen, Germany., O'Kane G; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada.; Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Ramotar S; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada.; Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Dodd A; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada.; Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Gallinger S; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada.; Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Muckenhuber A; Institute of Pathology, Technical University of Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Germany., Knox JJ; PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Canada.; Wallace McCain Centre for Pancreatic Cancer, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Kunzmann V; Department of Internal Medicine II, Medical Oncology, Comprehensive Cancer Center Mainfranken Würzburg, University Hospital Würzburg, Germany., Horn PA; Institute for Transfusion Medicine, University Hospital of Essen, Germany., Hoheisel JD; Division of Functional Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany., Siveke JT; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, a partnership between German Cabcer Research Center (DKFZ) and University Hospital Essen, Germany.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Lueong SS; German Cancer Consortium (DKTK), partner site Essen/Düsseldorf, a partnership between German Cabcer Research Center (DKFZ) and University Hospital Essen, Germany.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany. |
| Source: | Molecular oncology [Mol Oncol] 2025 Feb; Vol. 19 (2), pp. 357-376. Date of Electronic Publication: 2024 Oct 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
